FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN
Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma. L'invention concerne des formulations de composés...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LA, STEVEDAT K KELLY, RON C KENNEDY, MICHAEL T |
| description | Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma.
L'invention concerne des formulations de composés de formule I qui sont des doses et des schémas posologiques utiles dans des méthodes de traitement de cancer, notamment des malignités hématologiques telles que la leucémie myéloïde aiguë, le myélome multiple et le lymphome non hodgkinien. [INSÉRER LE COMPOSÉ ICI] |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3148965A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3148965A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3148965A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEsDqK-w72AQ6iKjtckbQ6aS2iucykSJ9FCfX_s4AM4_cP_bVVqYh-GDoUiZ0C2YGPG1mVYB6ANxJTF9cQtIJgYUhxWJB4FiD3VJBmC6TSkPooj3qvNY3ou5fDrTkHjxPhjmd9jWebpXl7lMxqs9Ol6u5xRV3-QLxtfLpU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN</title><source>esp@cenet</source><creator>LA, STEVEDAT K ; KELLY, RON C ; KENNEDY, MICHAEL T</creator><creatorcontrib>LA, STEVEDAT K ; KELLY, RON C ; KENNEDY, MICHAEL T</creatorcontrib><description>Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma.
L'invention concerne des formulations de composés de formule I qui sont des doses et des schémas posologiques utiles dans des méthodes de traitement de cancer, notamment des malignités hématologiques telles que la leucémie myéloïde aiguë, le myélome multiple et le lymphome non hodgkinien. [INSÉRER LE COMPOSÉ ICI]</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210204&DB=EPODOC&CC=CA&NR=3148965A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210204&DB=EPODOC&CC=CA&NR=3148965A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LA, STEVEDAT K</creatorcontrib><creatorcontrib>KELLY, RON C</creatorcontrib><creatorcontrib>KENNEDY, MICHAEL T</creatorcontrib><title>FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN</title><description>Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma.
L'invention concerne des formulations de composés de formule I qui sont des doses et des schémas posologiques utiles dans des méthodes de traitement de cancer, notamment des malignités hématologiques telles que la leucémie myéloïde aiguë, le myélome multiple et le lymphome non hodgkinien. [INSÉRER LE COMPOSÉ ICI]</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEsDqK-w72AQ6iKjtckbQ6aS2iucykSJ9FCfX_s4AM4_cP_bVVqYh-GDoUiZ0C2YGPG1mVYB6ANxJTF9cQtIJgYUhxWJB4FiD3VJBmC6TSkPooj3qvNY3ou5fDrTkHjxPhjmd9jWebpXl7lMxqs9Ol6u5xRV3-QLxtfLpU</recordid><startdate>20210204</startdate><enddate>20210204</enddate><creator>LA, STEVEDAT K</creator><creator>KELLY, RON C</creator><creator>KENNEDY, MICHAEL T</creator><scope>EVB</scope></search><sort><creationdate>20210204</creationdate><title>FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN</title><author>LA, STEVEDAT K ; KELLY, RON C ; KENNEDY, MICHAEL T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3148965A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LA, STEVEDAT K</creatorcontrib><creatorcontrib>KELLY, RON C</creatorcontrib><creatorcontrib>KENNEDY, MICHAEL T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LA, STEVEDAT K</au><au>KELLY, RON C</au><au>KENNEDY, MICHAEL T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN</title><date>2021-02-04</date><risdate>2021</risdate><abstract>Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma.
L'invention concerne des formulations de composés de formule I qui sont des doses et des schémas posologiques utiles dans des méthodes de traitement de cancer, notamment des malignités hématologiques telles que la leucémie myéloïde aiguë, le myélome multiple et le lymphome non hodgkinien. [INSÉRER LE COMPOSÉ ICI]</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3148965A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T19%3A39%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LA,%20STEVEDAT%20K&rft.date=2021-02-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3148965A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |